Leuko Is A Medical Technology Company Based In Bostonmassachusettsfounded In 2017 As An Mit Spinoutthe Company Focuses On Developing Non Invasive Medical Devices Aimed At Improving Clinical Outcomes For Patientsparticularly Those Undergoing Chemotherapyits Flagship Productpointcheckis A Portable Device That Monitors White Blood Cellwbclevels Without The Need For Blood Drawsthis Innovative Technology Uses Light And Ai Algorithmsallowing Patients To Monitor Their Health At Home And Potentially Reducing Hospital Admissions Related To Chemotherapy Leuko Primarily Serves The Healthcare Industrycollaborating With Leading Cancer Centers Such As Boston Medical Center And Md Anderson In The U S As Well As Dexeus And Hospital 12 De Octubre In Europethe Company Has Raised $12 49 Million In Fundingincluding A $5 Million Series A Round In 2022To Support Clinical Trials And Partnerships With Healthcare Providersleuko Aims To Significantly Impact Healthcare Costs And Patient Outcomeswith The Potential To Save Over $6 Billion Annually In The U Sby Reducing Chemotherapy Related Hospital Admissions
No conferences found for this company.
| Company Name | Leuko Labs Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
